BioCentury
ARTICLE | Company News

Andrx drug delivery, generics news

January 10, 2005 8:00 AM UTC

ADRX will exit its branded pharmaceuticals business to focus on generics and distribution. Banc of America Securities LLC will solicit offers for the branded business, which had an operating loss of $31 million for the first nine months of 2004. ...